Marina Biotech

Bothell, WA

Nasdaq: MRNA

Marina Biotech is a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). The company is currently employing two proven RNAi platforms to down-regulate the expression of specific proteins that cause disease: TauRNAi and TransKingdom RNAi. These approaches provide the flexibility to optimize oral, systemic and local delivery of RNAi-based therapies to target a wide range of human diseases based on the unique characteristics of the cells and organs involved in each disease.